Test 3 Flashcards

1
Q

Absorption

A

Process by which unchanged drug proceeds from the SOA to the site of measurement within the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Factors influencing absorption

A
Dose
Dosage form
Route of Administration
Physicochemical properties of drug
A&P at the site of abosrption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Barrier usually passed through in abosrption

A

Biological membrane of tissue barrier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diffusion

A

Passive. Depends on downward gradient. Obeys Ficks law.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Facilitated diffusion

A

Uses carrier molecules. Still needs gradient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Active transport

A

Carrier mediated. Needs energy, ATP. Can go against gradient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fick’s Law

A

Quantifies amount of substance that diffuses across a given surface area in an amount of time under certain concentration gradient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Gi Drug absorption

A

Transcellular- Through cells
Paracellular- In between cells. Small polar molecules.
Transcytosis- Uses Vesicle
M-cells- absorb it into lymphatic system. Microfolds of peyers patch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Gastric transit times

A

Stomach- 1 hr fasting, meal 2-8
Small intestine- 2-4
Large- 12-24

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What effect does gastric emptying have on drug absorption?

A

Can speed or delay it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Factors that effect drug permeability.

A

Lipophilicity- -1 to 4 best
Charge - neutral or unionized
size - less than 500mw
Presence of transporters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Absorption may be limited by…

A

Permeability or dissolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Blood flow can limit the rate of absorption for..

A

Highly permiable drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Highly permeable drugs are referred to as…

A

High extraction ration drugs. 70% or more taken up in single pass.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Eternal routes

A

By mouth, sublingual, Rectal (50% first pass)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Parenternal routes

A

IV, IM, Sub-Q, Intraspinal, Intraatrial,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How many genes code for transporters or transporter supporters?

A

2000 or 1/8 total

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ABC transporter

A

ATP binding casette. Active, need ATP. P-glycoprotein efflux system and CFTR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

SLC transporters

A

Solute carrier type. Facilitated and ion coupling. Can be drug targets or alter ADME. Serotonin and dopamine reuptake systems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Distribution is…

A

Reversible. Also non homogeneous, tissues differ in the rate and efficacy of drug uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Metabolism and Elimination are…

A

Non-Reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Drug distribution refers to?

A

The reversible transfer of free drug circulating in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Factor affecting drug distribution

A

Blood flow to clearance organisms, organ size, capillary bed surface area, capillary permeability, Influx and efflux systems, plasma protein binding, and presence of a disease in an organ.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Organ with high rates of blood flow

A

Lung, kidney, brain, and liver. Have high capillary surface area.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Organs with low rates of blood flow.

A

Resting muscle, skin, bone, and fat.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Perfusion or flow limited

A

Compounds in which uptake is sufficiently rapid that transfer is limited by delivery, not permeability. Usually smaller lipid soluble compounds with “high extraction ratios”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Permeability limited

A

Transfer across membrane is rate limiting. Polar, charged, and low lipid solubility usually. “Low extraction ratio”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Fenestra

A

Small porous membranes in some capillaries.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Free drug concentration can be affected by these 2 important factors.

A

Binding to plasma protein, ex, albumin.

Active transport back out of tissues by efflux pumps, ex. P-glycoprotein and MDRP4 systems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Plasma protein binding

A

Binding by these reduces free fraction of drug. Rarely leads to adverse drug events because of different binding sites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Albumin

A

Has 3 binding domains each with 2 subdomains.
Sudlow site 1 at 2a, warfarin binds here.
Sudlow site 2 at 3a, diazepam and ibu.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Lipoproteins

A

Allow drugs to piggy back

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Exchange between plasma and tissue is based upon…

A

Free drug concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Blood Brain Barrier.

A

Very picky to what it allows in. Capillaries lack pores and fenestra. Compounds must dissolve and diffuse across lipoid cell membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

CSF sink effect

A

Small amounts of some molecules that do cross barrier can be carried out with the more CSF flow so brain extracellular levels remain lower than those in the plasma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Xenobiotics

A

Things that can he harmful to us. The body has mechanisms to excrete such substances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Drug metabolism

A

Modifications made to drugs in order to get them excreted.Drugs can be activated (prodrugs) or inactivated by metabolism. Each metabolite of a drug had the possibility to be toxic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Top 2 drug metabolizing organs.

A

Liver and Gi tract.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Phase 1 metabolism

A

Oxidation, reduction, hydrolysis. Small changes to make substance more polar. Usually add O or N.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Phase 2 metabolism

A

Bigger changes to make more hydrophilic.

41
Q

Phase 3 metabolism

A

Excretion. Biliary or renal.

42
Q

Where are phase 1 and 2 enzymes located?

A

Phase 1 - In the Endoplasmic reticulum

Phase 2 - In the cytosol

43
Q

Cyclophosphamide

A

Pro drug. Induces apoptosis in cancer cells.

44
Q

Methotrexate and 5-fluorouracil

A

prodrugs. Block dTMP in cancer cells.

Methotrexate is folic acid analog that is polyglutamated in a cell.

45
Q

Cytochrome P450

A

Major phase 1 enzyme system located in smooth ER. NADPH cofactor required. Phase 2 UGT is nearby, exception to cytsol rule. Causes coupling between these phase 1 and 2 processes.

46
Q

What is homology percentage?

A

How many amino acids are the same in a CYP family.

47
Q

Enzymes that mediate Phase 1 but not CYP

A

Flavin monooxygenase isoenzymes
Alcohol Dehydrogenase
Aldehyde oxidase
Mooamine oxidase

48
Q

Three concers of CYP450 in drug therapy.

A

Inhibition of drug metabolism
induction of drug metabolism
Genetic polymorphism in population

49
Q

Inhibition of P450

A

Some substances compete for P450. EX. one drug can inhibit P450 while another being taken needs it to metabolize. May show saturation if inhibitor is a substrate, usually competitive inhibition, maybe allosteric, and slow parent drug metabolism can raise plasma conc.

50
Q

Induction of P450

A

Stuff to be broken down does so faster, stuff to get activated gets activated faster. Substance makes more P450 be made.

51
Q

Genetic polymorphism of P450

A

Some people just metabolize slower and some faster.

52
Q

APAP toxicity

A

Due to saturation of normal detox path. NAPQI metabolite binds to sulfhyryl groups in important proteins. Loss of intracellular calcium, disruption of mitochondrial function, and cell death.

53
Q

What protects cells form APA toxocity?

A

Glutathione reacts with toxic metabolites.

54
Q

Phase 2 metabolism

A

Covalent conjugation reactions, mostly in cytosol. Attach large hydrophilic endogenous groups. Ex. Glucuronic acid, glutathione, sulfate, acetic acid, and some amino acids.

55
Q

Enzymes that help conjugation?

A

Mainly UGT, sulfotranserases, methyl-T, Acetyl-T, Amino acid-T, Glutathione-T, and fatty acid conjugation.

56
Q

Glucuronidation

A

Most important in phase 2. Glucose and UTP make UDP-Glucose. UDP gulcose dehydrogenase makes UDP glucuronic acid. Finally UGT makes O-Glucuronide.

57
Q

Gilberts syndrome

A

Deffective UGT1A1. Bilirubin cant be conjugated.

58
Q

Enterophepatic Recycling

A

Drug glucuronide complexes excreted to gut can be broken down by B-glucuronidase. The released drug can be returned back to body, forming cycle and increasing drug half life.

59
Q

Acyl Glucuronides

A

Are unstable and can undergo hydrolysis or rearangment from C1 to C2, or C3 to C4 at neutral or alkaline PH. Can create toxic species.

60
Q

Sulfation

A

Done by sulfotransferases. Critical metabolism route for some drugs. Uses energy rigch sulfur donor PAPS.

61
Q

Sulfotransferases.

A

SULT or ST. Cytosolic enzyme in liver, kidney, gut, and brain. High affinity, low capacity.

62
Q

Acetaminophen

A

Is sulfated with sulfotransferase and PAPS. Estrone also does this.

63
Q

Methytransferase

A

Cystolic. Co-factor SAM. COMT is metabolism of catetholamines. Also done in desmethylimipramine.

64
Q

Thipourine methyl transferase.

A

TPMT. Significant metabolism of 6-Mercaptopurine with this is normal person. If genetically defective low activity of TPMT causes toxicity because of 6-thioguanine nucleotides.

65
Q

Phase 2 acetylations

A

Acetyl-CoA cofactor. Cystolic, NAT-1 and NAT-2 isoforms. In kupffer cells. CoASH left over after RXN.

66
Q

Glutathione conjugation

A

Bonds through nucleophilic cysteine thiol group. Very reactive with electrophilic substances.

67
Q

Fatty acid conjugation

A

Adds hydrocarbon tail onto site of phase 1 metabolism. Defies what we think of phase two because it makes drug more lipophilic.

68
Q

Drug elimination

A

Irreversible loss of drug from the body via metabolism or excretion.

69
Q

Metabolism

A

Loss of drug by chemical conversion.

70
Q

Excretion

A

Loss of drug by diffusion, filtration, evaporation, or transport process.

71
Q

Pharmacokinetics

A

Rate of elimination of a drug as the change in drug concentration with the passage of time. dC/dT.

72
Q

Rate of elimination =

A

-Ke*C^n

73
Q

If n=0

A

Zero order kinetics. aka. saturation kinetics

74
Q

If n=1

A

First order kinetics

75
Q

Zero order elimination

A

Independent of drug concentration.

Half life increases and clearance falls with increased drug conc.

76
Q

First order elimination

A

Dependent on drug concentration
Half life in independent of conc and constant.
Clearance is constant and not related to conc

77
Q

Rate constant, Ke

A

Function of slope of elimination time as conc falls. Dont confuse with elimination rate.

78
Q

Volume of distribution

A

Apparent volume in which a drug appears to be dissolved.

79
Q

Clearance

A

amount of blood from which drug can be metabolized or otherwise eliminated in a unit of time.
Cl=Rate of elimination / Drug Concentration

80
Q

Renal excretion

A

Glomerular filtration- Creates plasma like blood filtration
Tubular reabsorption- Takes useful stuff from filtrate back to blood
Tubular secretion- Removes additional blood waste and adds to filtrate

81
Q

Renal Elimination =

A

Glomerular filtration + tubular secretion - tubular reabsorption

82
Q

Macular densa

A

Special group of cells at distal tubules. Last check

83
Q

Juxtaglomerular apartaus

A

Macula densa and juxtaglomerular cells

84
Q

Clearance depends upon what?

A

Renal funtion. GFR.

Free drug clears easier than bound drug

85
Q

99% of filtered fluid is…

A

reabsorbed in the renal tubules. Occure by passive diffusion and active transport.

86
Q

Factors that influence reabsorption

A

Urine flow
Urine pH
Lipophilicity of Drug
Transport modulation

87
Q

Hepatic Excretion

A

Drugs actively transported from plasma to bile. Bilary excretion not good for drugs under 400 daltons. Conjugating to glucuronic acid helps with this excretion

88
Q

Enterohepatic circulation

A

Drugs excreted in bile un-conjugated by enzymes in GI tract. Reabsorbed in blood and re used. Increases half-life.

89
Q

Mammary secretion

A

Passive diffusion. Milk slightly acidic compared to blood.

90
Q

Toxicology

A

Study of adverse effects on living organisms. Includes symtoms, mechanisms, treatments, and detection of poisoning. Chief criteria for toxicity is amount or dose of substance that causes it.

91
Q

Procrustean Approach

A

Drugs often interact with multiple receptors.

92
Q

Therapeutic index

A

LD50/ED50 . Higher the ratio the safer the drug.

93
Q

Adverse drug reaction

A

Negative outcome due to drug.

94
Q

Adverse drug event

A

A negative outcome that occurs while taking a drug, but not necessarily attributed to it.

95
Q

Basis of allergic drug reactions

A

Most small drugs do not cause reactions. Must be presented to T-cell receptor via MHC. Must react covalently with protein to for a hapten.

96
Q

Acute toxicity

A

Uses a variety of doses and two animal species to determine LD50

97
Q

Subacute toxicity

A

Three doses in two species. Doses try to match those expected to be used clinically

98
Q

Chronic toxicty

A

Rodent and non rodent species, studies 6 months or longer.